The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksShield Thera Share News (STX)

Share Price Information for Shield Thera (STX)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1.55
Bid: 1.50
Ask: 1.60
Change: -0.10 (-6.06%)
Spread: 0.10 (6.667%)
Open: 1.65
High: 1.565
Low: 1.475
Prev. Close: 1.65
STX Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UK EXECUTIVE CHANGE SUMMARY: Shield Therapeutics Replaces Founder

Wed, 22nd Apr 2020 15:13

(Alliance News) - The following is a round-up of London-listed company director and manager changes announced on Monday, Tuesday and Wednesday and not separately reported by Alliance News:

----------

Shield Therapeutics PLC - pharmaceuticals - Tim Watts promoted to chief executive officer from chief financial officer, replacing the company's founder, Carl Sterritt. Shield said Sterritt, who formed the company in 2008, resigned "following discussions with major shareholders and with mutual agreement". Watts has been CFO since August 2018, previously having served in the same role at Oxford BioMedica PLC. Watts also worked at AstraZeneca PLC for 22 years.

----------

Bunzl PLC - distributor - Hires Vin Murria as non-executive director, starting June 1. Was founder & chief executive officer of Advanced Computer Software Group PLC. She is currently a non-executive director at Softcat PLC, DWF Group PLC and finnCap Group PLC.

----------

Mobile Streams PLC - data analytics platform - Peter Tomlinson resigns as director immediately, having been with the company for 20 years. Tomlinson stepped in as chair of Mobile Streams at the start of 2018, handing over to Nigel Burton late last year as the company raised equity following a vote by shareholders against delisting the company from AIM. Mobile Streams said Wednesday that Tomlinson "took over as chairman during a difficult time and supported the transition to a new management team".

----------

Metro Bank PLC - Gene Lockhart and Stuart Bernau step down as non-executive directors from May 18, replaced by Anne Grim, Ian Henderson, and Nicholas Winsor. Grim was chief customer officer for fund manager Fidelity International Ltd, and also worked for lenders Barclays PLC and Wells Fargo & Co. Henderson is CEO of Australian know-your-customer service provider Kyckr. Prior that he was chief operating officer for private banking businesses at Barclays Wealth and CEO of RBS International at Royal Bank of Scotland Group PLC. Winsor was CEO of several HSBC Holdings PLC businesses. Metro Bank noted its board now will consist of eight independent non-executive directors and two executive directors.

----------

Centrica PLC - Carlos Pascual and Steve Pusey will step down as non-executive directors from the annual general meeting on May 22.

----------

By Tom Waite; thomaslwaite@alliancenews.com

Copyright 2020 Alliance News Limited. All Rights Reserved.

More News
26 May 2020 08:58

Shield Therapeutics names Hans Peter Hasler as next chairman

(Sharecast News) - Pharmaceutical group Shield Therapeutics named Hans Peter Hasler as non-executive chairman of the company on Tuesday.

Read more
1 May 2020 13:28

UK TRADING UPDATE SUMMARY: Avacta, Genedrive Progress With Virus Tests

UK TRADING UPDATE SUMMARY: Avacta, Genedrive Progress With Virus Tests

Read more
1 May 2020 09:55

Shield Therapeutics FY revenues impacted by milestone repayment

(Sharecast News) - Pharmaceuticals outfit Shield Therapeutics warned on Friday that full-year revenues would be lower than originally anticipated after it had to repay a sizeable milestone payment.

Read more
18 Mar 2020 07:33

Shield Therapeutics Starts Independent Review Into Feraccru Study

Shield Therapeutics Starts Independent Review Into Feraccru Study

Read more
17 Mar 2020 15:17

Shield launches review after spotting flaw in 'Feraccru' study

(Sharecast News) - Commercial-stage pharmaceutical company Shield Therapeutics updated the market on the 'AEGIS-H2H' clinical trial on Tuesday, the data of which was primarily designed to be used in health economic analyses, pricing and reimbursement applications, as well as marketing purposes.

Read more
27 Jan 2020 15:07

Shield Therapeutics 2019 Revenue To Drop But Will Meet Expectations

Shield Therapeutics 2019 Revenue To Drop But Will Meet Expectations

Read more
27 Jan 2020 08:09

Shield Therapeutics details year of 'material progress'

(Sharecast News) - Drugs developer Shield Therapeutics told investors on Monday that 2019 had been a year of "material progress", with a key success being the recent Federal Drug Administration approval of its iron deficiency treatment, Feraccru/Accrufer.

Read more
8 Jan 2020 09:45

Shield Therapeutics Gets China Licence Agreement For Feraccru/Accrufer

Shield Therapeutics Gets China Licence Agreement For Feraccru/Accrufer

Read more
15 Aug 2019 14:28

DIRECTOR DEALINGS: Shield Therapeutics Chair Buys GBP134,000 In Shares

(Alliance News) - Shield Therapeutics PLC on Thursday said Chair James Karis acquired shares in the pharmaceutical company following a transaction on Tuesday.Karis purchased 75,000 shares a

Read more
7 Aug 2019 12:02

Shield Therapeutics Narrows Interim Losses Amid Expenses Fall

(Alliance News) - Drugmaker Shield Therapeutics said on Wednesday a payment from a commercial partner contributed to a sharp revenue rise in the first half of the year.In the six months to

Read more
3 Jun 2019 10:27

Teva Appeals Shield Therapeutics European Drug Patent Win

LONDON (Alliance News) - Shield Therapeutics PLC on Monday said Israeli pharmaceutical company Teva Pharmaceutical Industries Ltd has filed a notice of appeal on a decision regarding a Shield in a

Read more
26 Apr 2019 18:19

DIRECTOR DEALINGS: Shield Therapeutics Medical Chief Buys Shares

LONDON (Alliance News) - Shield Therapeutics PLC said on Friday that Chief Medical Officer Mark Sampson and his wife Julia have purchased shares in the company on Thursday.Mark bought at a

Read more
24 Apr 2019 12:22

Shield Therapeutics' Feraccru Granted Use Extension In Switzerland

LONDON (Alliance News) - Shield Therapeutics PLC said on Wednesday said the Swiss Agency for Therapeutic Products has approved the Feraccru product to treat iron deficiency in adults with or is to

Read more
17 Apr 2019 18:11

DIRECTOR DEALINGS: Shield Therapeutics Chair Buys GBP40,000 In Shares

LONDON (Alliance News) - Shield Therapeutics PLC said Wednesday Chair James Karis bought 50,000 shares in the company.Karis acquired 46,000 shares at GBP0.815 on Monday, then acquired a at

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.